Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.
about
Drug-induced amino acid deprivation as strategy for cancer therapy.Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations.Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets.Metabolite profiling reveals the glutathione biosynthetic pathway as a therapeutic target in triple negative breast cancer.Imaging Cancer Metabolism.Berberine and cinnamaldehyde together prevent lung carcinogenesis.Oncogene-Driven Metabolic Alterations in Cancer.PKM2 activation sensitizes cancer cells to growth inhibition by 2-deoxy-D-glucose.Targeted inhibition of glutaminase as a potential new approach for the treatment of NF1 associated soft tissue malignancies.The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer.Glutaminolysis Promotes Collagen Translation and Stability via α-ketoglutarate Mediated mTOR Activation and Proline Hydroxylation.Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.Resistant to Targeted Therapy - Aim for Metabolic Liabilities.
P2860
Q38657061-14817507-E8AF-425D-BE02-20226734FD55Q39232954-8CF87771-0CCD-4A0B-AE50-1C457C2C071AQ39340415-8A495A7B-771C-44A7-B84E-ADF8F9499A2DQ42516669-8C18C11C-3EC1-46B4-9F38-FE487308D796Q47117264-21ED6884-4171-49ED-8E57-6EFE96B3053DQ47132012-74B1C27E-A3C8-4220-AB25-B52D5AF8DD3CQ47159555-E5D4CB10-C5FC-4EB1-A05D-D0CCE9EE2877Q47251778-6F18F5F8-44D8-41B3-B365-9E1C78398F03Q49367042-85681900-46DC-4537-ABEE-0ED37DA463A2Q49887915-73C324CF-4806-4AA8-A42A-15A135E521CBQ50093331-C40E7B35-0A47-4FF3-A6BD-D5125538255FQ50113600-DD8AB7B9-C6AF-457E-A212-0C3217CAD0B5Q55195646-3CC71A5A-A4A0-4F30-A7FF-D2637BAE553A
P2860
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeted Inhibition of EGFR an ...... is in EGFR Mutant Lung Cancer.
@en
Targeted Inhibition of EGFR an ...... is in EGFR Mutant Lung Cancer.
@nl
type
label
Targeted Inhibition of EGFR an ...... is in EGFR Mutant Lung Cancer.
@en
Targeted Inhibition of EGFR an ...... is in EGFR Mutant Lung Cancer.
@nl
prefLabel
Targeted Inhibition of EGFR an ...... is in EGFR Mutant Lung Cancer.
@en
Targeted Inhibition of EGFR an ...... is in EGFR Mutant Lung Cancer.
@nl
P2093
P2860
P1433
P1476
Targeted Inhibition of EGFR an ...... is in EGFR Mutant Lung Cancer.
@en
P2093
Alison Pan
Andy Mackinnon
Clara Magyar
Daniel Braas
David B Shackelford
Edward Garon
Ethan Emberley
Francesco Parlati
Jason T Lee
Johannes Czernin
P2860
P304
P356
10.1016/J.CELREP.2016.12.061
P577
2017-01-01T00:00:00Z